|
|
D&C RED NO. 7 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
D&C RED NO. 30 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
AIRSUPRA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
AIRDUO DIGIHALER Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
ANGELIQ Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|